Related Experiment Video
Updated: Apr 17, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
14.0K
Sentinel lymph node biopsy for head and neck Merkel cell carcinoma: a preliminary study
A-S Ricard1, Q Sessiecq1, F Siberchicot1
1Service de Chirurgie Maxillo-Faciale, Centre François-Xavier-Michelet, Hôpital Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|February 14, 2015
Summary
Sentinel lymph node biopsy (SLNB) feasibility in head and neck Merkel cell carcinoma (MCC) was assessed. Results suggest SLNB may not be reliable for this aggressive cancer, requiring further study.
Area of Science:
- Oncology
- Surgical Oncology
Background:
- Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer.
- Head and neck MCC presents unique management challenges.
- Current management relies on limited data from small patient series.
Purpose of the Study:
- To evaluate the feasibility and preliminary outcomes of sentinel lymph node biopsy (SLNB) in head and neck MCC.
- To assess the utility of SLNB in staging and guiding treatment for MCC.
Main Methods:
- Retrospective analysis of 12 patients with stage I or II head and neck MCC.
- Patients underwent sentinel lymph node biopsy over a 4-year period.
Main Results:
- Sentinel lymph node biopsy was positive in only 1 of 12 patients.
- The sentinel node was not identified in 3 patients.
- Regional lymph node recurrence was observed in 2 of 8 patients with negative SLNB within 2 years.
Conclusions:
- Sentinel lymph node biopsy (SLNB) shows limited feasibility and diagnostic accuracy in head and neck MCC.
- The role of SLNB in the management of this aggressive malignancy requires further definition.
- High rates of recurrence in patients with negative SLNB highlight the need for refined staging and treatment protocols.
